Quantcast
Last updated on April 18, 2014 at 16:52 EDT

Latest Novartis Stories

2014-04-16 00:20:38

BASEL, Switzerland, April 16, 2014 /PRNewswire/ -- -- Strong start to European season -- Ongoing emerging market growth -- North American season delayed by weather -- On track to achieve full year sales growth target Sales in the first quarter of 2014 increased by 5 percent at constant exchange rates. The increase in reported sales was 2 percent owing to the depreciation of a number of emerging market currencies against the dollar. Integrated sales Integrated sales rose...

2014-04-14 12:34:19

DALLAS, April 14, 2014 /PRNewswire/ -- ReportsnReports.com offers Geriatric Medicine Development - Carving out New Opportunities to Treat Age-related Diseases 2014 market research report in its store at http://www.reportsnreports.com/reports/280698-geriatric-medicine-development-carving-out-new-opportunities-to-treat-age-related-diseases.html . Geriatric Medicine Development - Carving out New Opportunities to Treat Age-related Diseases report says despite the elderly...

2014-04-09 23:02:58

Comprehensive research report “OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017” worked out by GlobalData is now available at MarketPublishers.com. According to the study, by 2017-end, pancreatic cancer sales are projected to rise to USD 1.63 billion in the US and 5EU. London, UK (PRWEB) April 09, 2014 The pancreatic cancer market value in the US and 5EU (the six major markets, or 6MM) in 2012 was USD 529 million. Just over 50% of pancreatic cancer...

2014-04-09 12:31:33

DUBLIN, April 9, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/fkn6g5/vaccine_market_by) has announced the addition of the "Vaccine Market by Technology & Types, Various Classes & Indications - Global Forecasts To 2022" [http://www.researchandmarkets.com/research/fkn6g5/vaccine_market_by ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global vaccine technology...

2014-04-08 00:22:10

BASEL, Switzerland, April 8, 2014 -- Competition explores global challenges through compelling images -- The Award theme is "Scarcity-Waste" -- Open to professionals and amateurs, with $65,000 in prizes on offer /PRNewswire/ -- Syngenta today announced that the second Syngenta Photography Award is now open for entries. The Award aims to stimulate dialogue and create awareness around significant global challenges through powerful photography. The Syngenta Photography Award...

2014-04-07 08:31:14

BRIDGEWATER, N.J., April 7, 2014 /PRNewswire/ -- CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal and infectious disease, today announced the appointment of three new board members. "We are very pleased to welcome Cora M. Tellez, Taunia S. Markvicka, and Michael W. George to the CorMedix team. The addition of these highly accomplished industry veterans represents...

2014-04-03 08:29:00

- More than 50 abstracts highlight breadth and depth of Novartis Oncology pipeline and ability to test various combinations early to target multiple pathways EAST HANOVER, N.J., April 3, 2014 /PRNewswire/ -- Novartis announced today that early stage data on 19 investigational compounds in its oncology pipeline will be presented at the annual meeting of the American Association of Cancer Research (AACR), April 5-9, 2014 in San Diego, CA. The AACR annual meeting highlights basic, translational...

2014-03-28 12:22:04

DUBLIN, Mar. 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/44vxfn/investigation ) has announced the addition of the "Investigation Report on China Imatinib Market, 2009-2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Incidence of chronic myelogenous leukemia (CML) varies in the world. The global incidence is about 10/1,000,000 while in China it is 4/1,000,000. CML takes up about 20% of leukaemia in China...

2014-03-28 08:26:24

GAITHERSBURG, Md., March 28, 2014 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today reported financial results for the fourth quarter and year ended December 31, 2013. For the year ended December 31, 2013, the company reported a net loss of $10.0 million, or $0.77 per share, compared with a net loss of $14.1 million, or $1.09 per share, for the year ended December 31, 2012. GenVec ended the year with $6.1 million in cash, cash equivalents, and short-term investments. "Over the past six...

2014-03-26 12:26:51

BOSTON, March 26, 2014 /PRNewswire/ -- CBI is pleased to announce that Pharmaceutical Executive will reveal its prestigious Brand of the Year Award during iPharma 2014 - industry's leading marketing innovation summit - taking place May 8-9, 2014 in New York, NY. iPharma 2014 is the most compelling and comprehensive life sciences meeting, uniting key stakeholders in the world of digital marketing, strategy, branding, innovation, media, and IT to share the latest trends and real-world...